Promising new therapies for Behcet's disease
- 31 May 2006
- journal article
- review article
- Published by Elsevier BV in European Journal of Internal Medicine
- Vol. 17 (3), 163-169
- https://doi.org/10.1016/j.ejim.2005.11.011
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestationsJournal of Autoimmunity, 2004
- Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's diseaseArthritis & Rheumatism, 2004
- Behçet syndromeCurrent Opinion in Rheumatology, 2004
- MICA Transmembrane Region Polymorphism and HLA B51 in Tunisian Behçeťs Disease PatientsAdvances in experimental medicine and biology, 2002
- Behçet’s disease: Immunopathologic and therapeutic aspectsCurrent Rheumatology Reports, 2002
- A double-blind trial of colchicine in Beh et's syndromeArthritis & Rheumatism, 2001
- Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51Annals Of The Rheumatic Diseases, 2001
- Epidemiological Features and Visual Prognosis of Behçet's DiseaseJapanese Journal of Ophthalmology, 1999
- Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's diseaseClinical and Experimental Immunology, 1990
- Close Association of HLA-Bw51 With Behcet's DiseaseAmerican Journal of Ophthalmology, 1982